A Crash Course in the Pharmaceutical Industry R&D Proces

Explore how new drugs come to be, focusing on drug discovery and the steps toward development and approval within the pharmaceutical r&d process.

Explore the modern rational approach to drug discovery, from identifying disease targets and lead compounds to in vitro high throughput screening of a chemical library and selectivity assessment.

Explore how serendipity drives drug discovery, from accidental hits like penicillin and morphine to repurposing drugs for new indications, and contrast natural compounds, API concept, and purity in modern drugs.

Explore how captopril emerged as the first ACE inhibitor through natural venom insights, in vitro assays, chromatography, and rational drug design for hypertension.

Drug discovery combines a target-driven approach with high-throughput screening to generate leads and select a final drug candidate for development, while recognizing that serendipity also drives many drugs.

Outline preclinical studies and IND filing by detailing animal toxicity, pharmacology, formulation, and regulatory roles, leading from discovery to one compound and FDA submission.

Explore phase four postmarketing studies after approval, including extending indications and assessing risks, while noting concurrent nonclinical reproductive studies and carcinogenicity.

Introduce the early stages of drug development from preclinical and clinical work to drug approval and post-approval activities.

Explore FDA expedited review pathways, including accelerated approval based on biomarkers and the orphan drug act for rare diseases, plus post-marketing safety and GMP inspections.

Pair twenty-year patent life with FDA exclusivity to delay generics, including orphan seven years, pediatrics six months, and biologics twelve years.

Explore how generics must prove bioequivalence to originators, contrast small molecules with biosimilars, and examine the role of direct-to-consumer advertising and off-label use in the pharmaceutical landscape.

Explore the drug registration landscape, from FDA advisory committees and postmarket safety monitoring to orphan drug incentives, expedited reviews, and generic entry after patent and exclusivity expiry.

Discover protein-based biotech drugs, including monoclonal antibodies and hormones, produced by recombinant DNA technologies. Compare their high molecular weight, complex structures, injection administration, and regulatory biosimilar considerations.

Explore gene-based therapeutics, including cell therapy, gene therapy, and gene editing with CRISPR, from cancer to beta thalassemia and RNA vaccines.

Highlight future pharma trends: more biologicals, direct patient involvement, wearables, prevention, and genomics-driven, stratified therapies with companion diagnostics.

Experience a rewarding sense of contributing to people's health while your mind is challenged daily in pharm R&D. Enjoy a clean, safe environment, good pay, and collaborative colleagues.

Artificial intelligence accelerates pharmaceutical R&D by leveraging omics data to improve target identification, molecular design, predictive toxicology, and patient recruitment, reducing time and cost.

develop a focused, persistent job strategy in the pharmaceutical industry by defining your target area, aligning education and experience, and leveraging networking and internships to land a role.

celebrate finishing course and pursue entry roles in the pharmaceutical industry, stay persistent, build networks, attend conferences, and follow the literature, even starting in quality control with a bachelor's degree.